Invention Grant
- Patent Title: Cellular telomerase vaccine and its use for treating cancer
- Patent Title (中): 细胞端粒酶疫苗及其用于治疗癌症
-
Application No.: US11413838Application Date: 2006-04-27
-
Publication No.: US07824849B2Publication Date: 2010-11-02
- Inventor: Federico C. A. Gaeta
- Applicant: Federico C. A. Gaeta
- Applicant Address: US CA Menlo Park
- Assignee: Geron Corporation
- Current Assignee: Geron Corporation
- Current Assignee Address: US CA Menlo Park
- Agent David J. Earp; Leslie A. Mool
- Main IPC: C12Q1/00
- IPC: C12Q1/00
Abstract:
The invention provides dendritic cell (DC) preparations that present a telomerase reverse transcriptase (TRT) peptide in the context of an MHC class I or MHC class II molecule. The DCs may be pulsed with a TRT polypeptide, or may comprise a recombinant polynucleotide encoding TRT. The invention also describes the use of such compositions for the prevention and treatment of cancers and other diseases.
Public/Granted literature
- US20060204483A1 Cellular telomerase vaccine and its use for treating cancer Public/Granted day:2006-09-14
Information query
